glp 1 agonist therapy GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 Agonists: A Comprehensive Overview
Description
Insulin remains the preferred choice only when GLP-1 drugs are contraindicated, unaffordable, or insufficient alone, or when the patient has Type 1 diabetes
S1542356524004531
10.1371/journal.pone.0097554 38 KristensenS
doi: 10.1152/ajprenal.00064.2012
In a genetic preclinical study, embryonic GIPR knockout mice fed a high-fat diet were protected from obesity, supporting the role of GIPR antagonism as a method to promote weight loss and prevent weight gain (67)
[DOI] [PubMed] [Google Scholar] 503.Vilsboll T., Zdravkovic M., Le-Thi T., Krarup T., Schmitz O., Courreges J.P
